CV vs LNTH vs PHG Stock Comparison

CapsoVision, Lantheus Holdings and Koninklijke Philips Prices as of Nov 16, 2026 Peers: Industry group
CV CapsoVision, Inc
$6.47 -0.9% 1M +26.4% 1Y
Market cap
$334.51M
P/E
–
Revenue (TTM)
$13.92M
Div. yield
–
Diagnostic Equipment Healthcare
LNTH Lantheus Holdings, Inc.
$101.72 +2.0% 1M +91.9% 1Y
Market cap
$6.65B
P/E
24.6x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
PHG Koninklijke Philips Nv
$30.15 +17.1% 1M +5.2% 1Y
Market cap
$28.39B
P/E
14.9x
Revenue (TTM)
$30.13B
Div. yield
–
Diagnostic Equipment Healthcare
7 wins

Head to Head

11 decided of 12

Koninklijke Philips leads on 7 of the 12 questions below (Koninklijke Philips 7, Lantheus Holdings 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCVLNTHPHGLeader
Larger companyMarket capitalisation $334.51M $6.65B $28.39B PHG
Cheaper on earningsLower P/E, profitable companies only -11.4x 24.6x 14.9x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.4x 15.3x PHG
Faster revenue growthRevenue growth, trailing twelve months +6.4% +2.4% +53.4% PHG
More profitableNet margin, trailing twelve months -210.1% 17.3% 6.3% LNTH
Better return on capitalReturn on invested capital — 12.0% 12.1% PHG
Less leveragedLower net debt / EBITDA — -0.3x 1.7x LNTH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +26.4% +91.9% +5.2% LNTH
Better 5-year returnAnnualised price return, 5 years — +28.3%/yr -6.1%/yr LNTH
Less volatileAnnualised volatility, 1 year 95.6% 30.1% 29.5% PHG
Higher overall scoreMean of the five percentile scores vs peers 30/100 80/100 80/100 PHG

Percentile Scorecard

CVLNTHPHG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCVLNTHPHG
Valuation 12 #213 of 243 80 #49 of 243 98 #6 of 243
Growth 6 #214 of 228 70 #69 of 228 99 #3 of 228
Profitability 20 #179 of 222 96 #11 of 222 93 #17 of 222
Financial Health 90 #27 of 248 69 #77 of 248 30 #175 of 248
Shareholder Returns 23 #122 of 159 85 #24 of 159 81 #31 of 159
Overall 30 80 80
  • CV ranked among 252 companies in Medical Devices and Diagnostics
  • LNTH ranked among 252 companies in Medical Devices and Diagnostics
  • PHG ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCVLNTHPHGSPY
1 month -0.9%+2.0%+17.1% -3.0%
3 months +0.3%+0.8%+12.4% -4.2%
6 months +1.7%+9.2%+15.7% +0.2%
Year to date -39.5%+52.8%+11.3% +8.5%
1 year +26.4%+91.9%+5.2% +10.1%
3 years —+49.1%+42.6% +64.1%
3 years, per year —+14.3%+12.6% +18.0%
5 years —+247.3%-27.0% +58.1%
5 years, per year —+28.3%-6.1% +9.6%
10 years —+1,024.0%+5.3% +239.6%
10 years, per year —+27.4%+0.5% +13.0%

Risk

MeasureCVLNTHPHGSPY
Volatility, 1Y 95.6%30.1%29.5% 13.8%
Downside volatility, 1Y 88.8%24.7%27.4% 14.2%
Beta vs S&P 500, 1Y 0.710.450.82 1.00
Return / volatility, 1Y 0.283.050.18 0.74
Max drawdown, 5Y -67.8%-59.5%-72.2% -25.4%
From 52-week high -55.1%-8.3%-8.4% -5.0%
52-week high $14.42$110.94$32.91 $779.14
52-week low $4.64$52.50$23.81 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCVLNTHPHG
P/E now vs peer median -10.4xmedian 26.5x 24.6xmedian 26.5x 15.1xmedian 26.5x
P/S now vs peer median 23.2xmedian 2.7x 4.3xmedian 2.7x 1.0xmedian 2.7x
EV/EBITDA now vs peer median -10.3xmedian 18.6x 16.9xmedian 18.6x 8.5xmedian 18.6x
P/FCF now vs peer median -11.0xmedian 25.6x 16.9xmedian 25.6x 5.6xmedian 25.6x
P/B now vs peer median 12.3xmedian 2.5x 4.9xmedian 2.5x 2.2xmedian 2.5x
PEG now vs peer median —median 0.98 0.64median 0.98 0.22median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCVLNTHPHG
Revenue $13.92M $1.56B $30.13B
Gross profit $6.92M $957.06M $16.13B
Operating income -$29.52M $290.93M $2.79B
Net income -$29.25M $269.91M $1.45B
Free cash flow -$29.28M $393.09M $5.23B
R&D $20.27M $217.83M $1.99B
EPS (diluted) $-0.58 $3.95 $1.98
Cash & equivalents $21.76M $683.61M $3.12B
Total debt – $571.74M $10.22B
Shares (diluted) 50.57M 68.41M 962.50M
Enterprise value $275.63M $4.51B $16.66B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCVLNTHPHG
P/E -10.4x 24.6x 15.1x
P/FCF -11.0x 16.9x 5.6x
P/Operating cash flow -11.1x 16.2x 8.2x
P/S 23.2x 4.3x 1.0x
P/B 12.3x 4.9x 2.2x
P/Tangible book 12.3x 9.3x 2.8x
EV/EBITDA -10.3x 16.9x 8.5x
EV/EBIT -10.2x 22.5x 13.0x
EV/Revenue 21.6x 4.2x 1.2x
EV/FCF -10.3x 16.6x 6.9x
EV/Operating cash flow -10.3x 16.0x 10.2x
PEG (3Y EPS CAGR) – 0.64 0.22

Growth

14 metrics
MetricCVLNTHPHG
Revenue growth (1Y) 6.4% 2.4% 53.4%
Revenue CAGR (3Y) – 9.0% 15.1%
Gross profit growth (1Y) -0.5% 0.8% 76.3%
Gross profit CAGR (3Y) – 13.9% 4.0%
Operating income growth (1Y) -30.1% -16.3% 49.6%
Operating income CAGR (3Y) – 73.7% 337.8%
Net income growth (1Y) -29.6% 61.0% 444.3%
Net income CAGR (3Y) – 37.4% 45.2%
EPS growth (1Y) -18.5% 59.2% 177.7%
EPS CAGR (3Y) – 38.5% 69.9%
Operating cash flow growth (1Y) -41.9% -10.5% 154.0%
Operating cash flow CAGR (3Y) – 11.1% 70.2%
Free cash flow growth (1Y) -41.7% -5.1% 74.5%
Free cash flow CAGR (3Y) – 119.0% 39.5%

Profitability

14 metrics
MetricCVLNTHPHG
Gross margin 49.7% 61.3% 53.5%
EBITDA margin -210.4% 24.7% 14.1%
Operating margin -212.1% 18.6% 9.2%
Pretax margin -209.9% 21.9% 8.7%
Net margin -210.1% 17.3% 6.3%
FCF margin -210.3% 25.2% 17.4%
Operating cash flow margin -209.7% 26.2% 11.8%
Return on equity -148.0% 20.2% 13.2%
Return on assets -114.0% 11.1% 5.5%
Return on invested capital – 12.0% 12.1%
Return on capital employed -151.1% 13.9% 12.6%
Asset turnover 0.5x 0.6x 1.0x
Cash conversion (OCF / net income) 1.0x 1.5x 2.4x
Stock comp / revenue 14.8% 4.8% 0.5%

Financial Health

11 metrics
MetricCVLNTHPHG
Debt / assets – 23.3% 32.2%
Debt / equity – 0.4x 0.8x
Net debt / EBITDA – -0.3x 1.7x
Debt / FCF – 1.5x 2.0x
Liabilities / assets 19.5% 44.8% 58.7%
Equity / assets 80.5% 55.2% 41.3%
Interest coverage – 14.7x 6.5x
Current ratio 5.1x 3.2x 1.3x
Quick ratio 4.0x 3.0x 0.8x
Cash ratio 3.6x 2.0x 0.4x
Altman Z-score 21.14 5.54 –

Shareholder Returns

7 metrics
MetricCVLNTHPHG
Dividend yield – – 3.3%
Net buyback yield -4.4% 1.3% -0.7%
Shareholder yield -4.4% 1.3% 2.5%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCVLNTHPHG
Forward P/E – 17.4xFY2026 15.3xFY2026
EPS, next fiscal year $-0.58FY2026 $5.83FY2026 $1.99FY2026
EPS growth, next FY – -4.1%FY2026 +7.0%FY2026
EPS growth, the year after – +7.2% -10.6%
Revenue, next fiscal year $13.82MFY2026 $1.58BFY2026 $21.44BFY2026
Revenue growth, next FY +2.0%FY2026 +2.5%FY2026 +0.9%FY2026
Revenue growth, the year after +47.0% +12.6% -7.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCVLNTHPHG
Held by institutions 10.2% 100.0% 5.4%
Institutions holding 50 468 365
Change in shares held, QoQ +27.6% +3.4% +0.8%
Institutions buying 36 249 267
Institutions selling 8 143 76
Buyers to sellers 4.50 1.74 3.51

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CVLNTHPHG
CV 1.00 0.06 -0.01
LNTH 0.06 1.00 0.17
PHG -0.01 0.17 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CV, LNTH and PHG?

Koninklijke Philips (PHG) is the largest by market capitalisation: CapsoVision (CV) $334.51M, Lantheus Holdings (LNTH) $6.65B, Koninklijke Philips (PHG) $28.39B.

Which stock is cheaper, CV, LNTH and PHG?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (CapsoVision (CV) -11.4x, Lantheus Holdings (LNTH) 24.6x, Koninklijke Philips (PHG) 14.9x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Lantheus Holdings (LNTH) 17.4x, Koninklijke Philips (PHG) 15.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Koninklijke Philips (PHG) grew revenue fastest over the trailing twelve months: CapsoVision (CV) +6.4%, Lantheus Holdings (LNTH) +2.4%, Koninklijke Philips (PHG) +53.4%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (CapsoVision (CV) -210.1%, Lantheus Holdings (LNTH) 17.3%, Koninklijke Philips (PHG) 6.3%). On return on invested capital, Koninklijke Philips (PHG) leads (Lantheus Holdings (LNTH) 12.0%, Koninklijke Philips (PHG) 12.1%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: CapsoVision (CV) +26.4%, Lantheus Holdings (LNTH) +91.9%, Koninklijke Philips (PHG) +5.2%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Lantheus Holdings (LNTH) +28.3%/yr, Koninklijke Philips (PHG) -6.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (CapsoVision (CV) 95.6%, Lantheus Holdings (LNTH) 30.1%, Koninklijke Philips (PHG) 29.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CV, LNTH and PHG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.